Delivery Order SPE2DB24D2205-SPE2DB25FEFGB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $27,668.94 to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Priorix vials with a completion deadline of August 4, 2025. This firm fixed-price delivery order represents a competitive, non-set-aside award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99...
- The Defense Logistics Agency awarded a $1,755.30 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for Priorix vials, a measles, mumps, and rubella vaccine product. This firm fixed-price contract, with a completion date of July 29, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order will be fulfilled at AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Priorix vials, valued at $35,329.70. This firm fixed-price delivery order, which is expected to be completed by July 23, 2025, was issued without a set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $24,753 to AmerisourceBergen Drug Corp for Priorix vials, with an ultimate completion date of July 30, 2025. This non-set-aside contract was competitively awarded on a firm fixed price basis and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Priorix is a vaccine product, consistent with AmerisourceBergen's role as a critical pharmaceutical distributor for federal medical procurement. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,427.10 to AmerisourceBergen Drug Corp for Priorix vials on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed price delivery order was issued without a set-aside designation and represents a competitive award under the company's broader pharmaceutical supply agreement with DLA. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency Troop Support Medical awarded a $3,805.55 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561837158 units of Priorix vaccine vials. The place of performance is Amerisourcebergen's corporate office in Conshohocken, Pennsylvania. The period of performance is August 16-17, 2023. No additional details were provided regarding the original solicitation or whether this delivery order was placed against an existing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for PRIORIX vials valued at $10,892.18 under a Firm Fixed Price contract type. The award, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a non-set-aside competitive procurement. PRIORIX is a combination vaccine used for immunization against measles, mumps, rubella, and varicella, and this delivery order falls under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a $146,386.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562240240 Priorix vials. The single day contract has a period of performance from September 13, 2023 through September 14, 2023. DLA will utilize Amerisourcebergen's corporate office division located in Conshohocken, Pennsylvania to obtain the requested vials of Priorix, a measles, mumps and rubella vaccine, in support of DOD immunization programs. No subcontractors or...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for PRIORIX vials valued at $4,854.20 under a firm fixed-price contract. The award was made on July 29, 2025, with an ultimate completion date of July 30, 2025. No set-aside designation was used for this competitive award. The place of performance is listed as Conshohocken, Pennsylvania, which is AmerisourceBergen's corporate headquarters location. This delivery order represents a child contract under a...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order valued at one thousand six hundred thirty dollars and ninety-eight cents ($1,630.98) by the Defense Logistics Agency Troop Support Medical. The delivery order was issued against an indefinite delivery contract with no set aside designation used. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania by December 15, 2023. The delivery order is to supply forty-five hundred...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFGBDelivery Order
The Defense Logistics Agency awarded a $18,169.56 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Priorix vials with a completion date of July 24, 2025. This competitively awarded, non-set-aside contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Priorix, a measles-mumps-rubella combination vaccine, represents a critical medical commodity within the DLA's pharmaceutical procurement strategy. AmerisourceBergen's role as a prime vendor through the Troop Support Medical contract positions it to fulfill vaccine and immunization product requirements across the Defense Health Agency and other federal healthcare systems. This award demonstrates the company's continued capability to meet federal medical procurement requirements for specialized pharmaceutical products on a competitive basis through its established relationship with the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.2k | 7/23/25 |